FTC, FDA To Probe Generic Competition, PBMs, Purchaser Consolidation

An upcoming public workshop spearheaded by the Federal Trade Commission and FDA will delve into possible incentives for generic market entry, what can be done to address tactics used to stall generic competition, the role intermediaries play in drug pricing and how FTC can address these issues. In addition to looking at ways to speed generic entry, FTC and FDA will examine how pharmacy benefit managers and group purchasing organization affect drug pricing, access and quality, and how well consumers...